Drugs News and Research

RSS
Inflammation is a crucial and dangerous step in the development of obesity

Inflammation is a crucial and dangerous step in the development of obesity

New findings on antidepressants during pregnancy are reason for caution, not alarm

New findings on antidepressants during pregnancy are reason for caution, not alarm

Revatio now available in the UK

Revatio now available in the UK

Cat in the clear - but experts argue over "fire blanket" pandemic plan

Cat in the clear - but experts argue over "fire blanket" pandemic plan

MS sufferers lobby for return of Tysabri

MS sufferers lobby for return of Tysabri

Potential new treatment for Huntington and Parkinson patients

Potential new treatment for Huntington and Parkinson patients

Discovery of compound that reduces hallmark lesions of Alzheimer's disease in mice

Discovery of compound that reduces hallmark lesions of Alzheimer's disease in mice

Will the FDA rise to the occasion and admit their natalizumab mistake?

Will the FDA rise to the occasion and admit their natalizumab mistake?

Genes play a key role in stress response

Genes play a key role in stress response

Researchers discover cause of episodic ataxia type-2

Researchers discover cause of episodic ataxia type-2

Newly identified biomarkers may help reverse the ageing process

Newly identified biomarkers may help reverse the ageing process

Catheter ablation for chronic atrial fibrillation improves quality of life

Catheter ablation for chronic atrial fibrillation improves quality of life

Pharmaceutical brochures don't always present accurate data

Pharmaceutical brochures don't always present accurate data

Artificial intelligence addresses the problem of confusing drug names

Artificial intelligence addresses the problem of confusing drug names

Mutant genes trigger AMD but may lighten the way to new treatments

Mutant genes trigger AMD but may lighten the way to new treatments

SSRI use associated with increased risk for heart patients

SSRI use associated with increased risk for heart patients

New anti-drug program success

New anti-drug program success

Extensive study of natalizumab

Extensive study of natalizumab

5,000 rare diseases need drugs, but Europe only approves a handful each year

5,000 rare diseases need drugs, but Europe only approves a handful each year

Next-generation drug development: risky and costly, but worth it

Next-generation drug development: risky and costly, but worth it